University of Dundee
12 - 15 May 2019
The first conference of the Wellcome Centre for Anti-Infectives Research aims to harness cross-disciplinary and cross-disease learning to accelerate drug discovery and reduce drug candidate attrition rates for infectious diseases affecting low and middle income countries. Conference attendees will take home new ideas and technologies which have been demonstrated to work; applying them to diseases where challenges to drug discovery are hampering progress.
The conference has been formatted to allow active participation of all conference delegates. Each session will feature talks from internationally recognised experts followed by a panel discussion providing the opportunity for the audience to discuss the issues raised with the speakers. There will also be plenty of networking opportunities through poster sessions and evening social events.
The organising committee encourage researchers working within disease endemic countries to attend and bring their first-hand knowledge of the impact of infectious diseases to the discussions. 20 travel bursaries worth up to £1,500 are available to those coming from low and middle income countries to assist with the costs of attending the conference. Thank you to MMV, DNDi, Novartis BioMedical Research Institute and the Bill & Melinda Gates Foundation for sponsoring the travel bursaries.
Further information on registration, travel bursaries and abstract submission can be found on the conference website http://www.lifesci.dundee.ac.uk/research/events/wcair-conference-2019 .
Short-talks: 31st October 2018
Posters: 31st December 2018
Early Bird, closes 30th November 2018: £300
Registration from 1st December 2018: £375
Registration closes: 5th April 2019
Bree Aldridge, Tufts University, Boston; Clif Barry, National Institute of Allergy and Infectious Diseases, Bethesda; Manu De Rycker, University of Dundee; Natalie Gobeau, Medicines for Malaria Venture; Paul Herrling; Jennifer Keiser, Swiss Tropical and Public Health Institute; Paul Leeson, Medicinal Chemistry Consultant; Didier Leroy, Medicines for Malaria Venture; James McCarthy, QIMR Berghofer Medical Research Institute, Brisbane; Valerie Mizrahi, University of Cape Town; John Overington, Medicines Discovery Catapult; John Pottage, ViiV Healthcare; Isabela Ribeiro, Drugs for Neglected Diseases initiative; Lynn Silver, Anti-bacterial consultant; Thomas Spangenberg, Merck Global Health Institute; Shyam Sundar, Banaras Hindu University, Varanasi; Wesley Van Voorhis, University of Washington; Sir Nicholas White, Mahidol University, Thailand and Oxford University, UK; Susan Wyllie, University of Dundee.
Follow @WCAIRDundee #SOSID2019 for latest information on the conference.